Elanco Launches Credelio Plus for Dogs

Elanco completes parasiticide portfolio expansion with launch of Credelio™ Plus, offering vets a parasite treatment for every lifestyle for dogs

<br/> <img src = "https://assets-eu-01.kc-usercontent.com/7d1fb288-b93d-015d-f61e-abc4dbdfe522/494a6580-af5b-48da-9a32-42a6c6404790/MicrosoftTeams-image %283%29.png" height="300"></img> <p>Elanco Animal Health has completed the development of its comprehensive parasiticide portfolio with the marketing authorisation of Credelio™ Plus in the United Kingdom<sup>1</sup>. The launch supports the continued expansion of the Credelio™ franchise, which brings together a range of trusted solutions in Credelio™ tick and flea tablets for dogs, Credelio™ tiny tablets specially formulated for cats and now, Credelio™ Plus for all round parasite protection for dogs. Credelio™ Plus is a tasty, monthly, chewable tablet for dogs, providing protection against a variety of common parasitic species, including fleas, ticks, roundworm, lungworm, heartworm, hookworm and whipworm. Licensed for puppies as young as 8 weeks and weighing as little as 1.4 kg, Credelio™ Plus brings together two active ingredients, offering trusted worm control with milbemycin oxime plus immediate and persistent tick and flea kill with lotilaner. “Pets and owners have different habits and lifestyles, which affects their preferences for parasite products,” said William Hawker, Marketing Manager, Companion Animal Parasiticides, Elanco UK/Ireland. “Credelio™ Plus completes our parasiticide portfolio for Elanco and enables us to partner with vets to offer trusted solutions and support, for every pet’s lifestyle.” Making sure dogs are protected from internal and external parasites should be simple, convenient and fit with the different lifestyles of owners and their pets. <img src="https://assets-eu-01.kc-usercontent.com/7d1fb288-b93d-015d-f61e-abc4dbdfe522/f417a083-7f07-4d0c-8e64-1386a8792b55/Credelio%20Plus%20Banner%20Yoga%20dog%20Update%20v3.jpg"></img> “As a companion animal vet, one of the common challenges I see from pet owners is the need to remember and administer multiple treatments to cover a variety of parasites,” said Dr Cat Henstridge. “So a simple, easy-to-remember treatment will be welcomed by my clients who need a combination solution to protect their dogs from ticks, fleas and worms.” <img src="https://assets-eu-01.kc-usercontent.com/7d1fb288-b93d-015d-f61e-abc4dbdfe522/58b900c9-4741-4fc7-815b-58fec2a491a3/Portfolio%20Wheel%202022_Credelio%20Plus%20pop%20up%20v1.png" height="400" align="center"></img> Elanco’s parasite offering expanded rapidly following its acquisition of Bayer Animal Health in 2020, when Credelio™ and Milbemax™ were joined by Advocate™, Advantix™, Advantage™ and Seresto™. This expanded portfolio presents a parasite treatment for every lifestyle with the option of tablets, collars or spot-ons, meaning practices can now match the most convenient solutions to best suit their clients and their pets. <strong></strong> <img src="https://assets-eu-01.kc-usercontent.com/7d1fb288-b93d-015d-f61e-abc4dbdfe522/a6c9bf22-9752-4b19-97d1-0cb755cae8ef/Credelio%20Plus%20Launch%20Event%20Thumbnail_2022.jpg"></img> To mark the exciting launch of Credelio™ Plus and in anticipation of veterinary teams and clients reconnecting post-lockdown, Elanco hosted the launch event: “Into a new era”, a one-time exclusive event featuring a presentation from Cat Henstridge, better known to her online followers as 'Cat The Vet', about the power of wider veterinary teams working ‘better together’ to support each other, and how practices can start to reconnect with their clients following lockdown. Lepha McCartan, BVetMED MRCVS, Veterinary Technical Consultant, Elanco Animal Health, also spoke about Credelio Plus, the all-round parasite treatment. Did you miss the event? <a href="/cpd/credelio-plus-launch-webinar">Why not watch the 45 minute recording.</a> <hr/><strong>ABOUT CREDELIO™ PLUS </strong> Credelio™ Plus is a meat-flavoured monthly oral chewable tablet for dogs from 8 weeks of age and weighing as little as 1.4 kg, containing actives lotilaner (an isoxazoline) and milbemycin (a macrocyclic lactone) for the treatment of ecto- and endoparasites with a monthly dose. <strong>ABOUT ELANCO </strong> Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet. Learn more at www.elanco.com. <strong>Forward Looking Statements </strong> This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about our expectations concerning the combined Elanco and Bayer Animal Health businesses, including the ability to generate significant operating cash flow, and reflects Elanco’s current belief. Forward-looking statements are based on our current expectations and assumptions regarding our business and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, our actual results may differ materially from those contemplated by the forward-looking statements. For further discussion of these and other risks and uncertainties, see Elanco’s most recent filings with the United States Securities and Exchange Commission. Except as required by law, Elanco undertakes no duty to update forward-looking statements to reflect events after the date of this release. Credelio™ Plus contains lotilaner and milbemycin oxime. Legal category POM-V (UK) POM (IE). Credelio™ contains lotilaner. Legal category POM-V (UK) POM (IE). Milbemax™ contains milbemycin oxime and praziquantel. Legal category POM-V (UK) POM (IE). Advocate™ contains imidacloprid and moxidectin. Legal category POM-V (UK) POM (IE). Advantage™ contains imidacloprid. Legal Category: NFA-VPS in UK. Advantix™ contains imidacloprid and permethrin. Legal Category: POM-V in UK, POM in IE. Seresto™ Tick and Flea Control Collar contains imidacloprid and flumethrin. Legal Category: NFA-VPS in UK. Further information is available from the Summary of Product Characteristics. For further information call Elanco Animal Health on +44(0)1256 353131 or write to: Elanco UK AH Limited, incorporated in England and Wales, company no. 11378434, registered office at Form 2, Bartley Way, Bartley Wood Business Park, Hook, RG27 9XA, United Kingdom. Advice should be sought from the medicine prescriber prior to use. Credelio Plus, Credelio, Milbemax, Advocate, Advantage, Advantix, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. ©2022 Elanco or its affiliates. Use medicines responsibly www.noah.co.uk/responsible PM-IE-21-0140 Date of preparation: 05/22 <strong>References </strong> 1 CredelioTM Plus Summary of Product Characteristics. Available at https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_2067739.PDF. Last accessed April 2021. </p>

Share this page on

Related links

<a href="/brand/credelio-plus"><img src="https://assets-eu-01.kc-usercontent.com/7d1fb288-b93d-015d-f61e-abc4dbdfe522/7fe9a797-3856-4cb1-889d-8933167168b8/Credelio%20Plus%20thumbnail%20image%202022.png" alt="Credelio Plus for all-round parasite protection"><br><br>Learn more about Credelio Plus</a><br/>